No significant differences in the occurrence of NBS1 mutations were observed between different tumor stages, degrees of differentiation or the presence or absence of HBV infection in HCC cases (Table S1).No mutation was identified in poor differentiated tumors (Table 2, Table S1). This evidence concerns the gene NBN and hepatocellular carcinoma.